Market closed
Vivos Therapeutics Inc./$VVOS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Ticker
$VVOS
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
109
Website
VVOS Metrics
BasicAdvanced
$13M
-
-$2.22
7.28
-
Price and volume
Market cap
$13M
Beta
7.28
52-week high
$3.81
52-week low
$2.00
Average daily volume
82K
Financial strength
Current ratio
1.501
Quick ratio
1.344
Long term debt to equity
13.012
Total debt to equity
19.009
Management effectiveness
Return on assets (TTM)
-53.68%
Return on equity (TTM)
-266.25%
Valuation
Price to revenue (TTM)
0.751
Price to book
1.67
Price to tangible book (TTM)
2.8
Price to free cash flow (TTM)
-0.852
Growth
Revenue change (TTM)
8.91%
Earnings per share change (TTM)
-80.09%
3-year revenue growth (CAGR)
-3.80%
3-year earnings per share growth (CAGR)
-54.71%
VVOS News
AllArticlesVideos
Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 weeks ago
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
GlobeNewsWire·2 weeks ago
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Vivos Therapeutics Inc. stock?
Vivos Therapeutics Inc. (VVOS) has a market cap of $13M as of April 16, 2025.
What is the P/E ratio for Vivos Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Vivos Therapeutics Inc. (VVOS) stock is 0 as of April 16, 2025.
Does Vivos Therapeutics Inc. stock pay dividends?
No, Vivos Therapeutics Inc. (VVOS) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Vivos Therapeutics Inc. dividend payment date?
Vivos Therapeutics Inc. (VVOS) stock does not pay dividends to its shareholders.
What is the beta indicator for Vivos Therapeutics Inc.?
Vivos Therapeutics Inc. (VVOS) has a beta rating of 7.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.